Uveitis Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Corticosteroids, Immunosuppressant, Monoclonal Antibodies), By Disease Type, By Cause, By Distribution Channel, And Segment Forecasts, 2019 - 2026

Published: Jul, 2019 | Pages: 120 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global uveitis treatment market size is expected to reach USD 765.31 million by 2026, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 5.8% during the forecast period. Rising prevalence of the condition is anticipated to drive the growth. For instance, according to The Ocular Immunology and Uveitis Foundation, around 43,000 new eye inflammation cases are being diagnosed each year in U.S.

Eye inflammation is also very prevalent among children. However, majority of the affected population ranges from 20 to 50 years of age. Growing geriatric population is also an important factor driving the growth of the market. Rise in number of R&D activities aiming at new drug development is another attribute increasing the demand for these treatments.

For instance, ADX-102 Ophthalmic Solution, by Aldeyra Therapeutics, Inc. is in Phase 2 clinical trial for the treatment of noninfectious anterior uveitis. The National Eye Institute is also engaged in conducting and supporting various research studies in this field. Increasing prevalence of infectious diseases is another contributing factor to the market growth. Infectious uveitis surrounds a significant array of potential pathogens, which is likely to pose immense threat to the people affected.

Further key findings from the study suggest:

• Corticosteroids led the market in 2018 owing to its wide application for treating noninfectious uveitis as well as availability of varied corticosteroids drugs

• Monoclonal antibodies are expected to exhibit lucrative CAGR over the forecast period due to rising development of novel biologic drugs

• Anterior held the largest market share in 2018 owing to growing prevalence and tendency of recurrence of anterior uveitis

• Posterior is anticipated to showcase lucrative growth over the forecast period owing to rise in the number of R&D and clinical trials undergoing for the treatment posterior uveitis

• Noninfectious segment held significant revenue share in 2018 owing to the wide array of treatment methods coupled with rising cases of the condition

• Infectious segment is gaining traction in the uveitis treatment market owing to rising prevalence of infectious diseases

• North America held the largest revenue share in 2018 owing to increasing prevalence of noninfectious uveitis as well as rising healthcare expenditure in this region

• Asia Pacific is anticipated to exhibit lucrative CAGR over the forecast period due to the rising number of infectious diseases in the developing countries

• Few major companies are Allergan, Inc.; Valeant Pharmaceutical International, Inc.; Eyegate Pharmaceuticals, Inc.; AbbVie Inc.; Regeneron Pharmaceuticals, Inc; and Santen Pharmaceutical Co., Ltd

 Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation & Scope
                   1.2 Market Definition
                   1.3 Information Procurement
                       1.3.1 Purchased database
                       1.3.2 GVR's internal database
                       1.3.3 Secondary sources & third party perspectives
                       1.3.4 Primary research
                   1.4 Information Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market formulation & data visualization
                   1.6 Data Validation & Publishing
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Outlook
                   2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent market outlook
                       3.1.2 Related/ancillary market outlook
                   3.2 Penetration & Growth Prospect Mapping
                   3.3 User perspective analysis
                       3.3.1 Consumer Behavior Analysis
                       3.3.2 Market Influencer Analysis
                       3.3.3 List of Key End-users, by region / by product / by country
                   3.4 Regulatory Framework
                       3.4.1 Reimbursement framework
                       3.4.2 Standards & Compliances
                   3.5 Market Dynamics
                       3.5.1 Market Driver Analysis
                       3.5.2 Market Restraint Analysis
                       3.5.3 Industry Opportunity
                       3.5.4 Industry Challenges
                   3.6 Uveitis Treatment Market Analysis Tools
                       3.6.1 Industry Analysis - Porter's
                           3.6.1.1 Supplier Power
                           3.6.1.2 Buyer Power
                           3.6.1.3 Substitution Threat
                           3.6.1.4 Threat from new entrant
                           3.6.1.5 Competitive rivalry
                       3.6.2 PESTEL Analysis
                           3.6.2.1 Political Landscape
                           3.6.2.2 Environmental Landscape
                           3.6.2.3 Social Landscape
                           3.6.2.4 Technology Landscape
                           3.6.2.5 Legal Landscape
                       3.6.3 Major Deals & Strategic Alliances Analysis
                       3.6.4 Market Entry Strategies
                       3.6.5 Case Studies
Chapter 4 Uveitis Treatment Market: Competitive Analysis
                   4.1 Recent Developments & Impact Analysis, By Key Market Participants
                   4.2 Vendor Landscape
                       4.2.1 List of key distributors and channel partners
                       4.2.2 Key customers
                       4.2.3 Key company market share analysis, 2018
                   4.3 Public Companies
                       4.3.1 Company market position analysis
                       4.3.2 Company market Share/Ranking, by region
                       4.3.3 Competitive dashboard analysis
                           4.3.3.1 Market differentiators
                   4.4 Private companies
                       4.4.1 List of key emerging companies' /technology disruptors/innovators
                       4.4.2 Funding outlook
                       4.4.3 Regional network map
                       4.4.4 Company market position analysis
                       4.4.5 Supplier ranking
Chapter 5 Uveitis Treatment Market: Treatment Type Estimates and Trend Analysis
                   5.1 Definition and Scope
                   5.2 Treatment Type Market Share Analysis, 2018 & 2026
                   5.3 Segment Dashboard
                   5.4 Global Uveitis Treatment Market, by Treatment Type, 2015 - 2026 (USD Million)
                   5.5 Market Size & Forecasts and Trend Analysis, 2015 to 2026, by Treatment Type                   
                       5.5.1 Corticosteroids
                           5.5.1.1 Corticosteroids market, 2015 - 2026 (USD Million)
                       5.5.2 Immunosuppressant
                           5.5.2.1 Immunosuppressant market, 2015 - 2026 (USD Million)
                       5.5.3 Monoclonal Antibodies
                           5.5.3.1 Monoclonal antibodies market, 2015 - 2026 (USD Million)
                       5.5.4 Cycloplegic Agents
                           5.5.4.1 Cycloplegic agents market, 2015 - 2026 (USD Million)
                       5.5.5 Antibiotics
                           5.5.5.1 Antibiotics market, 2015 - 2026 (USD Million)
                       5.5.6 Antivirals
                           5.5.6.1 Antivirals market, 2015 - 2026 (USD Million)
                       5.5.7 Antifungal
                           5.5.7.1 Antifungal market, 2015 - 2026 (USD Million)
                       5.5.8 Analgesics
                           5.5.8.1 Analgesics market, 2015 - 2026 (USD Million)
Chapter 6 Uveitis Treatment Market: Disease Type Estimates and Trend Analysis
                   6.1 Definition and Scope
                   6.2 Disease Type Market Share Analysis, 2018 & 2026
                   6.3 Segment Dashboard
                   6.4 Global Uveitis Treatment Market, by Disease Type, 2015 - 2026 (USD Million)
                   6.5 Market Size & Forecasts and Trend Analysis, 2015 to 2026, by Disease Type
                       6.5.1 Anterior Uveitis
                           6.5.1.1 Anterior uveitis market, 2015 - 2026 (USD Million)
                       6.5.2 Posterior Uveitis
                           6.5.2.1 Posterior uveitis market, 2015 - 2026 (USD Million)
                       6.5.3 Intermediate Uveitis
                           6.5.3.1 Intermediate uveitis market, 2015 - 2026 (USD Million)
                       6.5.4 Panuveitis
                           6.5.4.1 Panuveitis market, 2015 - 2026 (USD Million)
Chapter 7 Uveitis Treatment Market: Cause Estimates and Trend Analysis
                   7.1 Definition and Scope
                   7.2 Cause Market Share Analysis, 2018 & 2026
                   7.3 Segment Dashboard
                   7.4 Global Uveitis Treatment Market, by Cause, 2015 - 2026 (USD Million)
                   7.5 Market Size & Forecasts and Trend Analysis, 2015 to 2026, by Cause
                       7.5.1 Infectious
                           7.5.1.1 Infectious market, 2015 - 2026 (USD Million)
                       7.5.2 Non-infectious
                           7.5.2.1 Non-infectious market, 2015 - 2026 (USD Million)
Chapter 8 Uveitis Treatment Market: Distribution Channel Estimates and Trend Analysis
                   8.1 Definition and Scope
                   8.2 Distribution Channel Market Share Analysis, 2018 & 2026
                   8.3 Segment Dashboard
                   8.4 Global Uveitis Treatment Market, by Distribution Channel, 2015 - 2026 (USD Million)
                   8.5 Market Size & Forecasts and Trend Analysis, 2015 to 2026, by Distribution Channel
                       8.5.1 Hospital Pharmacies
                           8.5.1.1 Hospital pharmacies market, 2015 - 2026 (USD Million)
                       8.5.2 Retail Pharmacies
                           8.5.2.1 Retail pharmacies market, 2015 - 2026 (USD Million)
                       8.5.3 Online Pharmacies
                           8.5.3.1 Online pharmacies market, 2015 - 2026 (USD Million)
Chapter 9 Uveitis Treatment Market Regional Estimates & Trend Analysis, by Treatment Type, Disease Type, Cause, Distribution Channel
                   9.1 Regional Market Snapshot
                   9.2 Regional Market Share and Leading Players, 2018
                       9.2.1 North America
                       9.2.2 Europe
                       9.2.3 Asia Pacific
                       9.2.4 Latin America
                       9.2.5 Middle East & Africa
                   9.3 Market Share Analysis by Country/ State
                       9.3.1 North America
                       9.3.2 Europe
                       9.3.3 Asia Pacific
                       9.3.4 Latin America
                       9.3.5 Middle East & Africa
                   9.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
                       9.4.1 North America
                       9.4.2 Europe
                       9.4.3 Asia Pacific
                       9.4.4 Latin America
                       9.4.5 Middle East & Africa
                   9.5 Market Size, & Forecasts and Trend Analysis, 2015 to 2026
                   9.6 North America
                       9.6.1 North America Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.6.2 U.S.
                           9.6.2.1 U.S. Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.6.3 Canada
                           9.6.3.1 Canada Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                   9.7 Europe
                       9.7.1 Europe Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.7.2 Germany
                           9.7.2.1 Germany Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.7.3 U.K.
                           9.7.3.1 U.K. Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.7.4 France
                           9.7.4.1 France Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.7.5 Italy
                           9.7.5.1 Italy Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.7.6 Spain
                           9.7.6.1 Spain Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.7.7 Russia
                           9.7.7.1 Russia Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                   9.8 Asia Pacific
                       9.8.1 Asia Pacific Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.8.2 Japan
                           9.8.2.1 Japan Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.8.3 China
                           9.8.3.1 China Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.8.4 India
                           9.8.4.1 India Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.8.5 South Korea
                           9.8.6.1 South Korea Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.8.7 Australia
                           9.8.7.1 Australia Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.8.8 Singapore
                           9.8.8.1 Singapore Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                   9.9 Latin America
                       9.9.1 Latin America Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.9.2 Brazil
                           9.9.2.1 Brazil Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.9.3 Mexico
                           9.9.3.1 Mexico Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.9.4 Argentina
                           9.9.4.1 Argentina Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                   9.10 Middle East and Africa
                       9.10.1 Middle East and Africa Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.10.2 South Africa
                           9.10.2.1 South Africa Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.10.3 Saudi Arabia
                           9.10.3.1 Saudi Arabia Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
                       9.10.4 UAE
                           9.10.4.1 UAE Market Size, & Forecasts and Trend Analysis, 2015 to 2026 (USD Million)
Chapter 10 COMPANY PROFILES
                   10.1 Allergan, Inc.
                       10.1.1 Company Overview
                       10.1.2 Financial performance
                       10.1.3 Product Benchmarking
                       11.1.4 Strategic Initiatives
                   10.2 Bausch & Lomb Incorporated.
                       10.2.1 Company Overview
                       10.2.2 Financial performance
                       10.2.3 Product Benchmarking
                       10.2.4 Strategic Initiatives
                   10.3 Novartis AG
                       10.3.1 Company Overview
                       10.3.2 Financial performance
                       10.3.3 Product Benchmarking
                       10.3.4 Strategic Initiatives
                   10.4 AbbVie Inc.
                       10.4.1 Company Overview
                       10.4.2 Financial performance
                       10.4.3 Product Benchmarking
                       10.4.4 Strategic Initiatives
                   10.5 Santen Pharmaceutical Co., Ltd
                       10.5.1 Company Overview
                       10.5.2 Financial performance
                       10.5.3 Product Benchmarking
                       10.5.4 Strategic Initiatives
                   10.6 Eyegate Pharmaceuticals, Inc.
                       10.6.1 Company Overview
                       10.6.2 Financial performance
                       10.6.3 Product Benchmarking
                       10.6.4 Strategic Initiatives
                   10.7 Alimera Sciences, Inc.
                       10.7.1 Company Overview
                       10.7.2 Financial performance
                       10.7.3 Product Benchmarking
                       10.7.4 Strategic Initiatives
                   10.8 Regeneron Pharmaceuticals, Inc
                       10.8.1 Company Overview
                       10.8.2 Financial performance
                       10.8.3 Product Benchmarking
                       10.8.4 Strategic Initiatives
                   10.9 Eyepoint pharmaceuticals Inc.
                       10.9.1 Company Overview
                       10.9.2 Financial performance
                       10.9.3 Product Benchmarking
                       10.9.4 Strategic Initiatives

List of Tables

TABLE 1 Factors used in segment share estimation
TABLE 2 List of secondary data sources
TABLE 3 Primary interview details, by source
TABLE 4 Primary interview details, by region
TABLE 5 North America uveitis treatment market, by country, 2015 - 2026 (USD Million)
TABLE 6 North America uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 7 North America uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 8 North America uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 9 North America uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 10 U.S. uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 11 U.S. uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 12 U.S. uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 13 U.S. uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 14 Canada uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 15 Canada uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 16 Canada uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 17 Canada uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 18 Europe uveitis treatment market, by country, 2015 - 2026 (USD Million)
TABLE 19 Europe uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 20 Europe uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 21 Europe uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 22 Europe uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 23 Germany uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 24 Germany uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 25 Germany uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 26 Germany uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 27 U.K. uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 28 U.K. uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 29 U.K. uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 30 U.K. uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 31 France uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 32 France uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 33 France uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 34 France uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 35 Italy uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 36 Italy uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 37 Italy uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 38 Italy uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 39 Spain uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 40 Spain uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 41 Spain uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 42 Spain uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 43 Russia uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 44 Russia uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 45 Russia uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 46 Russia uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 47 Asia Pacific uveitis treatment market, by country, 2015 - 2026 (USD Million)
TABLE 48 Asia Pacific uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 49 Asia Pacific uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 50 Asia Pacific uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 51 Asia Pacific uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 52 Japan uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 53 Japan uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 54 Japan uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 55 Japan uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 56 China uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 57 China uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 58 China uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 59 China uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 60 India uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 61 India uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 62 India uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 63 India uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 64 South Korea uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 65 South Korea uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 66 South Korea uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 67 South Korea uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 68 Australia uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 69 Australia uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 70 Australia uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 71 Australia uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 72 Singapore uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 73 Singapore uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 74 Singapore uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 75 Singapore uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 76 Latin America uveitis treatment market, by country, 2015 - 2026 (USD Million)
TABLE 77 Latin America uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 78 Latin America uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 79 Latin America uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 80 Latin America uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 81 Brazil uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 82 Brazil uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 83 Brazil uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 84 Brazil uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 85 Mexico uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 86 Mexico uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 87 Mexico uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 88 Mexico uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 89 Mexico uveitis treatment market, by end use, 2015 - 2026 (USD Million)
TABLE 90 Argentina uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 91 Argentina uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 92 Argentina uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 93 Argentina uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 94 MEA uveitis treatment market, by country, 2015 - 2026 (USD Million)
TABLE 95 MEA uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 96 MEA uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 97 MEA uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 98 MEA uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 99 South Africa uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 100 South Africa uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 101 South Africa uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 102 South Africa uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 103 Saudi Arabia uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 104 Saudi Arabia uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 105 Saudi Arabia uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 106 Saudi Arabia uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)
TABLE 107 UAE uveitis treatment market, by treatment type, 2015 - 2026 (USD Million)
TABLE 108 UAE uveitis treatment market, by disease type, 2015 - 2026 (USD Million)
TABLE 109 UAE uveitis treatment market, by cause, 2015 - 2026 (USD Million)
TABLE 110 UAE uveitis treatment market, by distribution channel, 2015 - 2026 (USD Million)

List of Figures

Fig. 1 Uveitis treatment market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Uveitis treatment market snapshot (2018)
Fig. 9 Uveitis treatment market: Segment snapshot (2018)
Fig. 10 Competitive Insights (2018)
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Consumer Behavior Analysis
Fig. 16 Uveitis treatment market driver impact
Fig. 17 Uveitis treatment market restraint impact
Fig. 18 Uveitis treatment industry challenges
Fig. 19 Uveitis treatment industry opportunity
Fig. 20 Porter's Five Forces Analysis
Fig. 21 SWOT Analysis, By Factor (Political & legal Economic and technological)
Fig. 22 Strategic Alliance Analysis
Fig. 23 Recent Developments & Impact Analysis, By Key Market Participants
Fig. 24 Key company market share analysis, 2018
Fig. 25 Company market position analysis
Fig. 26 Company Market Share/Ranking, by region
Fig. 27 Competitive dashboard analysis
Fig. 28 Company market position analysis
Fig. 29 Supplier Ranking
Fig. 30 Treatment type market share analysis, 2018 & 2026
Fig. 31 Segment Dashboard
Fig. 32 Global uveitis treatment market, by treatment type, 2015-2026 (USD Million)
Fig. 33 Corticosteroids market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 34 Immunosuppressant market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 35 Monoclonal antibodies market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 36 Cycloplegic agents market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 37 Antibiotics market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 38 Antivirals market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 39 Antifungal market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 40 Analgesics market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 41 Disease type market share analysis, 2018 & 2026
Fig. 42 Segment Dashboard
Fig. 43 Global uveitis treatment market, by disease type, 2015-2026 (USD Million)
Fig. 44 Anterior uveitis market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 45 Posterior uveitis market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 46 Intermediate uveitis market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 47 Panuveitis market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 48 Cause market share analysis, 2018 & 2026
Fig. 49 Segment Dashboard
Fig. 50 Global uveitis treatment market, by cause, 2015-2026 (USD Million)
Fig. 51 Infectious market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 52 Non-infectious market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 53 Distribution channel market share analysis, 2018 & 2026
Fig. 54 Segment Dashboard
Fig. 55 Global uveitis treatment market, by distribution channel, 2015-2026 (USD Million)
Fig. 56 Hospital pharmacies market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 57 Retail pharmacies market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 58 Online pharmacies market size & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 59 Uveitis Treatment market: Snapshot, 2018
Fig. 60 North America uveitis treatment market share and leading players, 2018
Fig. 61 Europe uveitis treatment market share and leading players, 2018
Fig. 62 Asia Pacific uveitis treatment market share and leading players, 2018
Fig. 63 Latin America uveitis treatment market share and leading players, 2018
Fig. 64 Middle East and Africa uveitis treatment market share and leading players, 2018
Fig. 65 North America market share analysis by country, 2018
Fig. 66 Europe market share analysis by country, 2018
Fig. 67 Asia Pacific market share analysis by country, 2018
Fig. 68 Latin America market share analysis by country, 2018
Fig. 69 Middle East and Africa market share analysis by country, 2018
Fig. 70 North America SWOT analysis, by factor (political & legal, economic and technological)
Fig. 71 Europe SWOT analysis, by factor (political & legal, economic and technological)
Fig. 72 Asia Pacific SWOT analysis, by factor (political & legal, economic and technological)
Fig. 73 Latin America SWOT analysis, by factor (political & legal, economic and technological)
Fig. 74 Middle East and Africa SWOT analysis, by factor (political & legal, economic and technological)
Fig. 75 North America market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 76 U.S. market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 77 Canada market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 78 Europe market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 79 Germany market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 80 U.K. market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 81 France market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 82 Italy market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 83 Spain market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 84 Russia market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 85 Asia Pacific market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 86 Japan market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 87 China market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 88 India market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 89 South Korea market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 90 Singapore market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 91 Australia market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 92 Latin America market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 93 Brazil market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 94 Mexico market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 95 Argentina market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 96 Middle East and Africa market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 97 South Africa market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 98 Saudi Arabia market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)
Fig. 99 UAE market size, & forecasts and trend analysis, 2015 to 2026 (USD Million)